National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Featured Clinical Trials

Cancer Studies Highlighted in the NCI Cancer Bulletin
< Back to Main

Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Search by Cancer Type
Breast Cancer

Colon and Rectal Cancer

Lung Cancer

Prostate Cancer

More Featured Trials
Search Featured Trials

      
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Questions about cancer?

1-800-4-CANCER
NCI Highlights
Restructuring the NCI Clinical Trials Enterprise

Clinical Trials Reporting Program

Coordinating Center for Clinical Trials

States Requiring Coverage of Clinical Trial Costs
You CAN Quit Smoking Now!
Related Pages
Search for Clinical Trials
NCI's PDQ® Cancer Clinical Trials Registry.

Prostate Cancer Home Page
NCI's gateway for information about prostate cancer.
Prostate Cancer - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

16.  Targeted Combination Therapy for Advanced Solid Tumors
(Posted: 07/19/2005) - In this study, researchers are assessing the safety and combined effectiveness of bevacizumab and a second drug called sorafenib. Both bevacizumab and sorafenib inhibit the formation of blood vessels to tumors and may act synergistically when combined.

17.  Hormone Therapy Plus Chemotherapy For Prostate Cancer
(Posted: 01/11/2005) - In this trial, researchers are investigating whether prostate cancer patients who receive chemotherapy at the start of androgen blockade live longer than patients who receive chemotherapy only after androgen blockade has stopped working.

18.  Vaccine Therapy for Advanced Prostate Cancer
(Posted: 11/23/2004) - The researchers conducting this trial have developed a comprehensive vaccine-based immunotherapy regimen that targets prostate-specific antigen (PSA), a protein made by both normal and cancerous epithelial cells of the prostate.

19.  Chemoprevention Trial for Men at High Risk for Prostate Cancer
(Posted: 04/27/2004) - Researchers are interested in determining whether a daily dose of the dietary supplement selenium might prevent prostate cancer in men at high risk for the disease.
< Previous  1 2 3 4 

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov